Also, similar to AD patients, individuals diagnosed with DLB had decreased levels of CSF Aβ1–42 compared to non-demented controls (p<0.001) however patients with DLB and PD did not differ from non-demented controls in respect to CSF T-tau or P-tau levels. The gene discussed is MAPT; the disease is Parkinson disease.